Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36AP13 (ribosomal protein L36a pseudogene 13) is a non-coding pseudogene found in the human genome, derived from the ribosomal protein L36a gene family. Unlike its parent gene, RPL36A, which encodes a protein component of the large ribosomal subunit, RPL36AP13 does not produce a functional protein and is considered biologically inactive. Pseudogenes such as RPL36AP13 may be used for evolutionary studies or genomic annotation, but do not have direct functional roles in cellular biology or as therapeutic drug targets. In summary: RPL36AP13 is a pseudogene, not a receptor, enzyme, or any druggable therapeutic target. It is accurately identified, but not functionally relevant for drug discovery, molecular targeting, or biomarker use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 13 (RPL36AP13).